Johannes F. Fahrmann, Ph.D.
Affiliations: | 2013 | Biomedical Sciences | Marshall University, Huntington, WV, United States |
Area:
Biochemistry, Cell Biology, OncologyGoogle:
"Johannes Fahrmann"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Wanda Elaine DuBois Hardman | grad student | 2013 | Marshall University | |
| (Omega-3 fatty acids as therapeutic options for the treatment of B-cell chronic lymphocytic leukemia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li YJ, Fahrmann JF, Aftabizadeh M, et al. (2022) Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids. Cell Reports. 39: 110870 |
| Abbas A, Witte T, Patterson WL, et al. (2021) Epigenetic Reprogramming Mediated by Maternal Diet Rich in Omega-3 Fatty Acids Protects From Breast Cancer Development in F1 Offspring. Frontiers in Cell and Developmental Biology. 9: 682593 |
| Mukherjee A, Chiang CY, Daifotis HA, et al. (2020) Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance. Cancer Research |
| Mukherjee A, Coscia F, Fahrmann J, et al. (2018) Abstract A15: Fatty acid binding protein 4 is indispensable for ovarian cancer metastasis Clinical Cancer Research. 24 |
| Fahrmann JF, Hardman WE. (2013) Omega 3 fatty acids increase the chemo-sensitivity of B-CLL-derived cell lines EHEB and MEC-2 and of B-PLL-derived cell line JVM-2 to anti-cancer drugs doxorubicin, vincristine and fludarabine. Lipids in Health and Disease. 12: 36 |
| Fahrmann JF, Ballester OF, Ballester G, et al. (2013) Inhibition of nuclear factor kappa B activation in early-stage chronic lymphocytic leukemia by omega-3 fatty acids. Cancer Investigation. 31: 24-38 |
| Ballester OFF, Fahrmann J, Witte T, et al. (2010) Oral Supplementation with Omega3 Fatty Acids Inhibits NFkB Activation In Chronic Lymphocytic Leukemia (CLL) Cells. Blood. 116: 4607-4607 |